Showing 3801-3810 of 8867 results for "".
- Continuous Abrocitinib Use Linked to Better Long-Term AD Outcomes: Studyhttps://practicaldermatology.com/news/continuous-abrocitinib-use-linked-to-better-long-term-ad-outcomes-study/2473925/A new real-world study suggests that sustained abrocitinib treatment and adherence to the full 12-week induction phase improved outcomes and delay relapse in patients with moderate to severe atopic dermatitis (AD). "Although c
- Study Highlights Gaps in Dermatology PA Certification Exam Coveragehttps://practicaldermatology.com/news/research-highlights-gaps-dermatology-pa-certification-exam-coverage/2466960/New research suggests that the prevalence of skin disease burden in the United States generally aligns with the physician assistant (PA) certification exam, with areas for improvement. According to the new study published in the Journal of Dermatology Physicians Assistants, the National C
- Is CBG the Next CBD for Skincare?https://practicaldermatology.com/news/is-cbg-the-next-cbd-for-skincare/2461042/Cannabigerol (CBG) shows antioxidant, anti-inflammatory, and skin health-boosting activity in lab assays and provides similar benefits when applied topically to human skin, according to new research. In a single-blind c
- Almirall Completes Investment in Suneva Medicalhttps://practicaldermatology.com/news/almirall-completes-investment-in-suneva-medical/2458900/Barcelona-based Almirall, a global pharmaceutical company, has closed a $15 million in Series C equity investment in Suneva Medical, Inc., marketer of Bellafill®. This product i
- Christina Cosmeceuticals Launches e-Commerce Websitehttps://practicaldermatology.com/news/20120816-christina_cosmeceuticals_launches_e-commerce_website/2459752/Christina Cosmeceuticals launched their first US e-commerce website for licensed aesthetic professionals. The site allows members to order products and supplies while acting as a resource for spa and aesthetician needs. Content showcases C
- Incoming AAD President Dr. Taylor Pledges to 'Take Care of Dermatologists'https://practicaldermatology.com/news/Incoming-AAD-President-Dr-Taylor-Pledges-Take-Care-Dermatologists/2471549/The theme of the next American Academy of Dermatology (AAD) presidency will be taking care of dermatologists so that they can take care of their patients, incoming president Susan C. Taylor, MD, FAAD, said in an address at the 2025 AAD Annual Meeting in Orlando, Florida. “Just as we treat
- Care Urged for Adult-Onset AD Diagnoseshttps://practicaldermatology.com/news/Care-Urged-Adult-Onset-AD-Diagnoses/2471216/As revolutionary as the latest approved therapeutics for atopic dermatitis have been, Daniela Kroshinsky, MD, MPH, cautioned that dermatologists must be vigilant and consider biopsies for atypical or nonresponsive cases before starting dupilumab or a JAK inhibitor. Speaking at the Winter C
- Acne Vaccine Could Be 'Revolutionary,' Dr. Stein Gold Sayshttps://practicaldermatology.com/news/Acne-Vaccine-Could-Be-Revolutionary-Dr-Stein-Gold-Says/2471165/The next major breakthrough in acne could be a “revolutionary” vaccine targeting the strain of c. Acnes bacteria that produces the Hyl-A enzyme, Linda Stein Gold, MD, said at the Winter Clinical Hawaii 2025 meeting in Waikoloa Village, Hawaii. “It is still in early clinical trials, but I t
- Review: Potential and Challenges for Exosomes in Cosmetic Dermatologyhttps://practicaldermatology.com/news/review-potential-and-challenges-exosomes-cosmetic-dermatology/2470764/Exosomes show promise for enhancing skin and hair health, but key challenges must be addressed before they can be widely adopted in cosmetic dermatology, according to a new literature review in the Journal of Drugs in Dermatology. Exosomes, extracellular vesicles responsible for cellular c
- Study: TPC2 Ion Channel Key Driver of Melanoma Progressionhttps://practicaldermatology.com/news/study-tpc2-ion-channel-key-driver-melanoma-progression/2468665/New research has succeeded in identifying a critical regulator of melanoma progression. The research, published by a group from Ludwig-Maximilians-Universität München in Nature Communications, highlights how TPC2 influences intracellular trafficking pathways that drive melanoma c